Rucaparib is a revolutionary drug in the field of oncology, offering hope to patients with advanced ovarian, fallopian tube, and peritoneal cancers. As a poly (ADP-ribose) polymerase (PARP) inhibitor, Rucaparib plays a crucial role in targeting and destroying cancer cells, particularly in patients with BRCA mutations. The increasing demand for this life-saving drug underscores the importance of...